Antimicrobial activity in cord blood units: Occurrence and levels of antibiotics

Transfusion

Volumn 54, Issue 10, 2014, Pages 2505-2513

  Cayer, Marie Pierre ^a   Girard, Mélissa ^a   Fournier, Diane ^a   Delage, Gilles ^a   Thibault, Louis ^a  

^a HÉMA QUÉBEC   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; BETA LACTAMASE; PENICILLIN G; ANTIINFECTIVE AGENT; PENICILLIN DERIVATIVE;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM CONTAMINATION; BACTEROIDES FRAGILIS; BACTEROIDES UNIFORMIS; BLOOD TRANSFUSION; CRYOPRESERVATION; DISK DIFFUSION; ESCHERICHIA COLI; FEMALE; HUMAN; INCIDENCE; KLEBSIELLA PNEUMONIAE; MEDICAL RECORD; MICROCOCCUS LUTEUS; NONHUMAN; PLASMA VOLUME; PROPIONIBACTERIUM ACNES; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STEM CELL; STREPTOCOCCUS AGALACTIAE; UMBILICAL CORD BLOOD; BLOOD; BLOOD DONOR; COMPLEMENT ACTIVATION; CYTOLOGY; DOSE RESPONSE; DRUG EFFECTS; FETUS BLOOD; HEMATOPOIETIC STEM CELL; METABOLISM; MICROBIOLOGY; NEWBORN; STATISTICS AND NUMERICAL DATA;

AMPICILLIN; ANTI-INFECTIVE AGENTS; ANTIBIOTIC PROPHYLAXIS; BETA-LACTAMASES; BLOOD DONORS; COMPLEMENT ACTIVATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FETAL BLOOD; HEMATOPOIETIC STEM CELLS; HUMANS; INFANT, NEWBORN; PENICILLINS;

EID: 84908089827     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12655     Document Type: Article

References (34)

1. Food and Drug Administration. Minimally manipulated, unrelated allogeneic placental/umbilical cord blood intended for hematopoietic reconstitution for specified indications. Rockville (MD): Food and Drug Administration; 2009.
2. American Association of Blood Banks. Standards for cellular therapy product services. 4th ed. Bethesda (MD): American Association of Blood Banks; 2010.
3. NetCord and the Foundation for the Accreditation of Cellular Therapy (FACT). NetCord-FACT international standards for cord blood collection, processing, testing, banking, selection, and release. 3rd ed. Omaha (NE): NetCord-FACT; 2008.
4. Riedel S, Junkins A, Stamper PD, et al. Comparison of the Bactec 9240 and BacT/Alert blood culture systems for evaluation of placental cord blood for transfusion in neonates. J Clin Microbiol 2009; 47: 1645-1649.
5. Khuu HM, Patel N, Carter CS, et al. Sterility testing of cell therapy products: parallel comparison of automated methods with a CFR-compliant method. Transfusion 2006; 46: 2071-2082.
6. Solves P, Planelles D, Mirabet V, et al. Qualitative and quantitative cell recovery in umbilical cord blood processed by two automated devices in routine cord blood banking: a comparative study. Blood Transfus 2013; 11: 405-411.
7. Zhu L, Lv H, Wang Y, et al. Microbial screening of unrelated cord blood units in a Chinese cord blood bank. Transfus Med 2013; 23: 438-441.
8. M-Reboredo N, Diaz A, Castro A, et al. Collection, processing and cryopreservation of umbilical cord blood for unrelated transplantation. Bone Marrow Transplant 2000; 26: 1263-1270.
9. Akel S, Lorenz J, Regan D,. Sterility testing of minimally manipulated cord blood products: validation of growth-based automated culture systems. Transfusion 2013; 53: 3251-3261.
10. Mastronardi C, Yang L, Halpenny M, et al. Evaluation of the sterility testing process of hematopoietic stem cells at Canadian Blood Services. Transfusion 2012; 52: 1778-1784.
11. Strunk T, Doherty D, Richmond P, et al. Reduced levels of antimicrobial proteins and peptides in human cord blood plasma. Arch Dis Child Fetal Neonatal Ed 2009; 94: F230-231.
12. Schuchat A,. Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin Microbiol Rev 1998; 11: 497-513.
13. Verani JR, McGee L, Schrag SJ,. Prevention of perinatal group B streptococcal disease-revised guidelines from CDC, 2010. MMWR Recomm Rep 2010; 59 (RR-10): 1-36.
14. Money D, Allen VM,. The prevention of early-onset neonatal group B streptococcal disease. J Obstet Gynaecol Can 2013; 35: 939-951.
15. Gilstrap LC 3rd, Bawdon RE, Burris J,. Antibiotic concentration in maternal blood, cord blood, and placental membranes in chorioamnionitis. Obstet Gynecol 1988; 72: 124-125.
16. Honohan A, Olthuis H, Bernards AT, et al. Microbial contamination of cord blood stem cells. Vox Sang 2002; 82: 32-38.
17. Meyer TP, Hofmann B, Zaisserer J, et al. Analysis and cryopreservation of hematopoietic stem and progenitor cells from umbilical cord blood. Cytotherapy 2006; 8: 265-276.
18. Burnouf T, Chou ML, Wu YW, et al. Antimicrobial activity of platelet (PLT)-poor plasma, PLT-rich plasma, PLT gel, and solvent/detergent-treated PLT lysate biomaterials against wound bacteria. Transfusion 2013; 53: 138-146.
19. Dussault D, Vu KD, Lacroix M,. In vitro evaluation of antimicrobial activities of various commercial essential oils, oleoresin and pure compounds against food pathogens and application in ham. Meat Sci 2014; 96: 514-520.
20. Holten KB, Onusko EM,. Appropriate prescribing of oral beta-lactam antibiotics. Am Fam Physician 2000; 62: 611-620.
21. Hirsch JG,. Demonstration by fluorescence microscopy of adsorption onto bacteria of a heat-labile factor from guinea pig serum. J Immunol 1964; 92: 155-158.
22. Faust K, Gopel W, Moser K, et al. Differential expression of antimicrobial polypeptides in cord blood samples of preterm and term infants. Acta Paediatr 2014; 103: e143-147.
23. Allen JL, Sprunt K,. Discrepancy between minimum inhibitory and minimum bactericidal concentrations of penicillin for group A and group B beta-hemolytic streptococci. J Pediatr 1978; 93: 69-71.
24. Bloom SL, Cox SM, Bawdon RE, et al. Ampicillin for neonatal group B streptococcal prophylaxis: how rapidly can bactericidal concentrations be achieved? Am J Obstet Gynecol 1996; 175 (4 Pt 1): 974-976.
25. Clark P, Trickett A, Chimenti M, et al. Optimization of microbial screening for cord blood. Transfusion 2014; 54: 550-559.
26. Flayhart D, Borek AP, Wakefield T, et al. Comparison of BACTEC PLUS blood culture media to BacT/Alert FA blood culture media for detection of bacterial pathogens in samples containing therapeutic levels of antibiotics. J Clin Microbiol 2007; 45: 816-821.
27. McDonald LC, Weinstein MP, Fune J, et al. Controlled comparison of BacT/ALERT FAN aerobic medium and BATEC fungal blood culture medium for detection of fungemia. J Clin Microbiol 2001; 39: 622-624.
28. Spaargaren J, van Boven CP, Voorn GP,. Effectiveness of resins in neutralizing antibiotic activities in Bactec Plus Aerobic/F culture medium. J Clin Microbiol 1998; 36: 3731-3733.
29. Vetter E, Torgerson C, Feuker A, et al. Comparison of the BACTEC MYCO/F Lytic bottle to the isolator tube, BACTEC Plus Aerobic F/bottle, and BACTEC Anaerobic Lytic/10 bottle and comparison of the BACTEC Plus Aerobic F/bottle to the Isolator tube for recovery of bacteria, mycobacteria, and fungi from blood. J Clin Microbiol 2001; 39: 4380-4386.
30. Wen ZM, Ye ST,. Skin testing in patients with high risk of anaphylactic reactions to penicillin. Asian Pac J Allergy Immunol 1993; 11: 13-18.
31. Jacobs JF, Baumert JL, Brons PP, et al. Anaphylaxis from passive transfer of peanut allergen in a blood product. N Engl J Med 2011; 364: 1981-1982.
32. Poisson JL, Riedo FX, Aubuchon JP,. Acquired peanut hypersensitivity after transfusion. Transfusion 2014; 54: 256-257.
33. Choi S, Hoffmann S, Cooling L,. Another case of acute cardiopulmonary toxicity with cord blood infusion: is dextran the culprit? Transfusion 2012; 52: 207-208.
34. Foundation for the Accreditation of Cellular Therapy (FACT). Washing and/or diluting cord blood units with red cells is an important patient safety measure. Bethesda (MD). Just the Fact; Spring 2013 [cited 2014 Feb 17]. Available from: http://www.factwebsite.org/uploadedFiles/Just-the-FACTs-Newsletter/Spring%202013.pdf